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Abstract
Background: Artesunate plus sulphadoxine-pyrimethamine is one of the four artemisinin-based combination therapies
currently recommended by WHO as first-line treatment for falciparum malaria. Sulphadoxine-pyrimethamine is also used
for intermittent preventive treatment for malaria in pregnancy. Drug use patterns and drug pharmacokinetics are
important factors impacting the spread of drug resistant parasites hence it is imperative to monitor the effect of
pharmacokinetic variability on therapeutic efficacy. Unfortunately, information on the pharmacokinetics of sulphadoxine
in children and pregnant women with malaria is very limited. Methods for the assay of sulphadoxine-pyrimethamine have
been previously reported, but they are not cost-effective and practicable in analytical laboratories in low resource areas
where malaria is endemic. Efforts in this study were thus devoted to development and evaluation of a simple, cost-
effective and sensitive method for quantification of sulphadoxine in small capillary samples of whole blood dried on filter
paper.
Methods: Sulphadoxine was determined in whole blood by reversed-phase high performance liquid chromatography
with UV detection at 340 nm. Sulisoxazole (SLX) was used as internal standard. Chromatographic separation was
achieved using a Beckman Coulter ODS C18 and a mobile phase consisting of 0.05 M phosphate buffer-methanol-
acetonitrile (70:17:13 V/V/V) containing 1% triethylamine solution.
Results: Standard curves from sulphadoxine-spiked blood added to filter paper were linear over the concentration range
studied. Linear regression analysis yielded correlation coefficient r2 > 0.99 (n = 6). Extraction recoveries were about 82-
85%. The limit of quantification was 120 ng/ml while the within and between assay coefficient of variations were < 10%.
The inter-day precision was < 5.8% and inter-day accuracy ranged from 4.1 to 5.3%. There was no interference from
endogenous compounds or any of the commonly used anti-malarial, analgesic and anti-infective drugs with the peaks of
SDX or the internal standard.
Conclusion: The recovery and accuracy of determination of SDX from whole blood filter paper samples using the
method described in this study is satisfactory, thus making the method a valuable tool in epidemiological studies and
therapeutic drug monitoring in developing endemic countries. Furthermore, the applicability of the method in studying
the pharmacokinetic disposition of SDX in a patient suggests that the method is suitable in malaria endemic areas.
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Background
Malaria remains a major public health problem in disease
endemic areas affecting mostly young children and preg-
nant women. Presently, the artemisinin-based combina-
tion therapy (ACT) is now recommended as first line
treatment for falciparum malaria [1]. Artesunate plus sul-
phadoxine-pyrimethamine is one of the four ACT cur-
rently recommended by WHO [1] for definitive treatment
of malaria, while sulphadoxine-pyrimethamine is also
used for intermittent preventive treatment for malaria in
pregnancy (IPTp) [2] and in infants (IPTPi) [3]. In areas
where sulphadoxine-pyrimethamine remains effective,
the combination of artesunate with sulphadoxine-
pyrimethamine enhances the clinical outcome.
Drug use patterns and drug pharmacokinetics are some of
the factors which impact the spread of drug resistant par-
asites hence the importance of monitoring the effect of
pharmacokinetic variability on therapeutic efficacy can-
not be overemphasized. Information on the pharmacoki-
netics of sulphadoxine in children and pregnant women
with malaria is very limited. Thus simple, cost effective
and sensitive methods for quantification of sulphadoxine
and pyrimethamine in small capillary samples of biologi-
cal fluids dried on filter are necessary.
Although, methods for the assay of sulphadoxine-
pyrimethamine have been previously reported, they are
not cost effective requiring the use of large volume of
blood/plasma, freezing facilities or expensive instrumen-
tation, such as solid phase extraction, photodiode detec-
tor or mass spectrophotometer [4-6]. These methods may
not be very practicable in analytical laboratories in low
resource areas where malaria is endemic. In addition,
some of the previous methods used sulphamethoxazole
as internal standard [7]. This compound is a component
of co-trimoxazole, which is commonly used to treat bac-
terial infections in some countries including Nigeria and
which could interfere with analysis. Presented in this
report, is the development and evaluation of a simple,
cost-effective two-step extraction procedure, using a
reverse-phased chromatographic system with UV detec-
tion for the assay of sulphadoxine in whole blood using
filter paper. This method would be useful in epidemiolog-
ical and pharmacokinetic studies in malaria endemic
countries where resources are scarce.
Methods
Chemicals
Sulphadoxine (Hoffman La Roche, Basel, Switzerland)
and sulisoxazole were obtained from Dr. Dennis Kyle,
Walter Reed Army Research Institute, USA. Sulisoxazole
was used as internal standard. All solvents used were
HPLC grade (Merck, D-6100 Darmstadt, Germany) while
hydrochloric acid, phosphoric acid and all other reagents
employed were analytical grade BDH (Poole, UK). Sul-
phadoxine-pyrimethamine tablets (Fansidar®, Swiss
Pharma Nigeria Ltd, under license of F. Hoffmann-La
Roche, Basel Switzerland) were purchased locally from a
wholesale Pharmacy in Ibadan, Nigeria. Filter papers
(Whatman®, Maidstone, UK) were also purchased locally.
Instrumentation
The separation of sulphadoxine was carried out under iso-
cratic condition at room temperature. The HPLC system
consisted of a Cecil 4100 pump), attached to Cecil 4200
variable wavelength UV-Visible detector set at 340 nm.
The chromatograms were recorded and analyzed with
PowerStream software (CE 4900) provided with the
instrument (Cecil Instrument, Cambridge, England).
Chromatographic separation was achieved using a
reversed-phased Ultrasphere ODS 15 cm × 4.6 mm I.D 5
μm C18 column (Beckman, USA) maintained at room
temperature. The mobile phase consisted of 0.05 M phos-
phate buffer-methanol-acetonitrile (70:17:13 V/V/V) con-
taining 1% triethylamine solution and adjusted to pH 3.4
with phosphoric acid. Elution was carried out at room
temperature and the flow rate was 0.9 ml/min. A syringe
loading sample injector model 7725 (Rheodyne L.P., Cal-
ifornia, USA) was used for sample injection onto the
HPLC column.
Calibration and sample preparation
Stock solutions of sulphadoxine (SDX) (1 mg/ml) and the
internal standard, sulisoxazole (SLX) (1 mg/ml) was pre-
pared in 70% methanol. Working solutions of the drugs
were prepared by appropriate serial dilution in 0.1 N HCl
to yield 100 μg/ml and 500 μg/ml of SDX and SLX respec-
tively. Drug free human whole blood was spiked with the
working solution of SDX to yield final concentrations of
100, 80, 40, 20, 10, 5, and 0 μg/ml of sulphadoxine. The
resulting solutions were used to develop and evaluate the
method. Using an adjustable pipette, 100 μl of spiked
whole blood was adsorbed onto Whatman filter paper.
The samples were dried at room temperature overnight.
Filter papers were stored in desiccated resealable plastic
bags at room temperature if they were not to be assayed
immediately.
Extraction procedure
The dried drug-spiked spot of whole blood on filter paper
were cut into small pieces. All the pieces from each sample
were transferred into clean 15 ml polypropylene centri-
fuge tubes containing twenty microlitre (20 μl) of 500 μg/
ml SLX as internal standard (IS) and 200 μl 0.1 NHCl and
soaked for 30 minutes. The extraction solvent acetonitrile
(2 ml) was added and the mixture was vortexed for two
minutes and thereafter centrifuged for 10 minutes at 2000
g. The supernatant was transferred into a clean centrifuge
tube and dried under a stream of nitrogen gas in a waterMalaria Journal 2009, 8:238 http://www.malariajournal.com/content/8/1/238
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bath at 50°C. The sample was reconstituted in one hun-
dred microlitres (100 μl) of 0.1 N HCl, vortexed for 2
minutes and an aliquot (20 μl) was injected onto the col-
umn.
Precision, accuracy and recovery
Sample preparation and extraction were performed on six
replicates at each concentration of sulphadoxine on each
of six days. Calibration curves were prepared from the
measurement of peak height ratios of the analytes and
internal standard. To assess precision and reproducibility
of the method, coefficients of variation (CVs) and stand-
ard deviations were determined for intra- and inter-assay
variability. Recovery was determined for each concentra-
tion by comparison of peak height ratio of the extracted
known standards with the directly injected standard con-
centrations.
Interference
Commonly used anti-malarial, analgesic and anti-infec-
tive drugs including chloroquine, mefloquine, quinine,
amodiaquine, paracetamol, sulphamethoxazole and tri-
methoprim were studied for interference by spiking the
drugs in blank whole blood. The drugs were extracted
according to the method described above. The presence of
peaks was monitored after injection of 20 ul of the recon-
stituted sample.
Stability
The stability of sulphadoxine blood samples dried on fil-
ter paper samples has been previously reported [7].
Clinical evaluation
In order to evaluate the clinical application of this
method, one hundred microlitre (100 μl) of capillary
blood obtained from a patient with acute uncomplicated
Plasmodium falciparum malaria who had taken a standard
single oral dose of 25 mg/kg sulphadoxine-pyrimeth-
amine (based on the sulphadoxine component) was spot-
ted on filter paper. Whole blood samples were taken on
days 0 before drug administration and days 1, 2, 3, 4, 5, 6,
7, 14 and 28 after drug administration following verbal
informed consent from patient's guardian. Samples were
dried and extracted as described above.
Results
Evaluation of the analytical procedure
Standard curves from sulphadoxine-spiked blood added
to filter paper were linear over the concentration range
studied. Linear regression analysis yielded correlation
coefficient r2 > 0.99 (n = 6) (Figure 1). The baseline of sul-
phadoxine and the internal standard were well resolved at
the calibration ranges of 5 - 100 μg/ml with retention
times of 6.3 and 7.2 min for sulphadoxine and sulisoxa-
zole respectively (Figure 2A). The separation chromato-
grams of sulphadoxine and the internal standard from
spiked whole blood samples (Figure 2A) corresponded
with those of blood samples obtained from a patient at
time 0 before drug administration and day 3 after an oral
standard dose of sulphadoxine-pyrimethamine (25 mg/kg
body weight of sulphadoxine component and 1.25 mg/kg
body weight pyrimethamine component) (Figure 2B and
2C respectively).
Recovery, calibration curves and reproducibility
The extraction recoveries for 25 μg/ml, 60 μg/ml and 100
μg/ml of sulphadoxine were 82.66% ± 4.09 (n = 6),
81.02% ± 3.24 (n = 5) and 85.60% ± 1.98 (n = 5) respec-
tively. The intra-day recovery deviation at 60 μg/ml and
100 μg/ml of SDX were 3.7% and 4.6% respectively (n =
5). The inter-day precision was < 5.8% and inter-day accu-
racy ranged from 4.1 to 5.3%. The limit of detection was
120 ng/ml at 0.05 absorbance units full-scale (aufs).
Interference
There was no interference from endogenous compounds
or any of the commonly used anti-malarial, analgesic and
anti-infective drugs with the peaks of SDX or the internal
standard.
Clinical application
The concentration-time profile of SDX in whole blood in
the individual who took a standard single oral dose of sul-
phadoxine-pyrimethamine (SP) (25 mg/kg body weight
of sulphadoxine and 1.25 mg/kg body weight pyrimeth-
amine) is shown in Figure 3. The pharmacokinetic param-
eters of SDX in the individual are shown in table 1. Peak
blood concentration was 212.02 μg/ml. The calculated
elimination half-life was 3.50 days while the area under
Calibration curve for sulphadoxine in whole blood Figure 1
Calibration curve for sulphadoxine in whole blood.
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(A) separation of sulphadoxine (1) and internal standard (2) from whole blood spiked with 60 μg/ml sulphadoxine Figure 2
(A) separation of sulphadoxine (1) and internal standard (2) from whole blood spiked with 60  g/ml sulphadox-
ine. (B) and (C) chromatograms of day 0 and day 3 whole blood samples collected from a patient who received a standard sin-
gle dose of sulphadoxine-pyrimethamine (25 mg/kg body weight of sulphadoxine component and 1.25 mg/kg body weight of 
pyrimethamine component).
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the concentration time curve (AUC0-28) was 884.84 μg/
ml.day. The profile shows the applicability of the method
for measuring SDX in whole blood dried on filter paper.
Discussion
Filter paper methods are suitable for field use because they
require small volume of blood samples and no freezing
facilities. The method described in this report involves
two simple extraction steps followed by drying, reconsti-
tution and injection into the chromatographic system.
The recovery and accuracy of determination of SDX from
whole blood filter paper samples using this method is sat-
isfactory thus making the method a valuable tool in epi-
demiological studies and therapeutic drug monitoring in
developing endemic countries. Recovery may however
have been better without affecting cost of analysis, if the
extraction had been performed with two aliquots of one
millilitre each of acetonitrile as opposed to one aliquot of
two millilitres of acetonitrile. The applicability of the
method in studying the pharmacokinetic disposition of
SDX in a patient suggests that the method is suitable in
malaria endemic areas. In this method, sulisoxazole was
used as internal standard. Sulisoxazole is not a commonly
used sulpha drug in this area, thus it is very convenient in
determination methods because there is rare likelihood of
interference with drugs previously taken by patients or
volunteers. However, a limitation of this method is that it
did not detect pyrimethamine in whole blood samples
although the pyrimethamine peak was separated from the
sulphadoxine peak in spiked whole blood samples. Thus
there will not be any interference of peaks during analysis.
Lack of detection of pyrimethamine in patient samples
may be attributable to the wavelength for detection not
being optimal for pyrimethamine. Previous studies have
however shown that knowledge of the SDX concentration
provides some information on the magnitude of the
accompanying PYR concentrations [7].
The present method can be used in conjunction with the
simple pyrimethamine method described by Minzi [8] to
study sulphadoxine-pyrimethamine drug combination.
The present method is simple, cost effective and practical
in resource poor settings compared to previously reported
methods which require use of larger volumes of blood,
freezing facilities or expensive instrumentation [4-6],
although it requires a relatively time consuming organic
solvent evaporation step. It would be useful in monitor-
ing sulphadoxine level following IPT in infants (IPTi) or
pregnant women (IPTp) with sulphadoxine-pyrimeth-
amine or during treatment of falciparum malaria with
artesunate-sulphadoxine/pyrimethamine or any combi-
nation therapy that may involve a sulfa-based compound
for malaria treatment especially in resource poor malaria
endemic areas.
Conclusion
The applicability of this method in studying pharmacoki-
netic disposition of sulphadoxine in a patient suggests
that the method is suitable in malaria endemic areas. In
addition the ability to quantify sulphadoxine in whole
blood using a sensitive and cost-effective assay makes the
method useful in epidemiological studies and therapeutic
drug monitoring in low resource settings.
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Pharmacokinetic profile of sulphadoxine in whole blood after  administration of single oral dose of sulphadoxine-pyrimeth- amine (25 mg/kg body weight of sulphadoxine and 1.25 mg/kg  body weight of pyrimethamine) Figure 3
Pharmacokinetic profile of sulphadoxine in whole 
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Table 1: Pharmacokinetic parameters of sulphadoxine in a 
patient with falciparum malaria treated with a single standard 
oral dose of sulphadoxine-pyrimethamine tablet.
Parameter
T 1/2 (day) 3.50
Cmax (μg/ml) 212.02
AUC0-28 (μg/ml.day) 884.84
AUC0-28: Area under the blood concentration-time curve from time 0 
to day 28
Cmax: Peak blood concentration
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